Literature DB >> 16238548

New insights into the families of PLC enzymes: looking back and going forward.

Matilda Katan1.   

Abstract

A study in this issue of the Biochemical Journal by Harden and colleagues, in association with one published in the Biochemical Journal very recently [Hwang, Oh, Shin, Kim, Ryu and Suh (2005) Biochem. J. 389, 181-186], have defined a new member of the superfamily of PLC (phosphoinositide-specific phospholipase C) enzymes, PLCeta. Two isoforms, PLCeta1 and PLCeta2, and their splice variants add to the molecular diversity of PLC enzymes. The studies of PLCeta regulation suggest that at least some splice variants of PLCeta2 could be regulated by the G-protein subunits Gbetagamma. As two other families, PLCbeta and PLC, are also regulated through heterotrimeric G-proteins, this finding reveals further complexity and possible interplay between different PLC families and their regulatory networks. At this point, when it is likely that the PLCeta family completes the effort of identifying new members of this related group of PLC enzymes, I also discuss some more general concepts of PLC regulation and catalysis, and challenges awaiting their further studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16238548      PMCID: PMC1276975          DOI: 10.1042/BJ20051506

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

Review 1.  Ras effectors: buying shares in Ras plc.

Authors:  P J Cullen
Journal:  Curr Biol       Date:  2001-05-01       Impact factor: 10.834

Review 2.  Structure, function, and control of phosphoinositide-specific phospholipase C.

Authors:  M J Rebecchi; S N Pentyala
Journal:  Physiol Rev       Date:  2000-10       Impact factor: 37.312

3.  Molecules interacting with PRIP-2, a novel Ins(1,4,5)P3 binding protein type 2: Comparison with PRIP-1.

Authors:  Ayako Uji; Miho Matsuda; Toshio Kukita; Katsumasa Maeda; Takashi Kanematsu; Masato Hirata
Journal:  Life Sci       Date:  2002-12-20       Impact factor: 5.037

Review 4.  PLC-epsilon: a shared effector protein in Ras-, Rho-, and G alpha beta gamma-mediated signaling.

Authors:  Michele R Wing; David M Bourdon; T Kendall Harden
Journal:  Mol Interv       Date:  2003-08

5.  A novel phospholipase C, PLC(eta)2, is a neuron-specific isozyme.

Authors:  Masamichi Nakahara; Makoto Shimozawa; Yoshikazu Nakamura; Yasuhiro Irino; Mitsuhiro Morita; Yoshihisa Kudo; Kiyoko Fukami
Journal:  J Biol Chem       Date:  2005-05-17       Impact factor: 5.157

Review 6.  Regulation of phosphoinositide-specific phospholipase C.

Authors:  S G Rhee
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

7.  Two distantly positioned PDZ domains mediate multivalent INAD-phospholipase C interactions essential for G protein-coupled signaling.

Authors:  R van Huizen; K Miller; D M Chen; Y Li; Z C Lai; R W Raab; W S Stark; R D Shortridge; M Li
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

8.  Molecular cloning and characterization of PLC-eta2.

Authors:  Yixing Zhou; Michele R Wing; John Sondek; T Kendall Harden
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

Review 9.  Phosphoinositides and signal transduction.

Authors:  A Toker
Journal:  Cell Mol Life Sci       Date:  2002-05       Impact factor: 9.261

10.  PLC zeta: a sperm-specific trigger of Ca(2+) oscillations in eggs and embryo development.

Authors:  Christopher M Saunders; Mark G Larman; John Parrington; Llewellyn J Cox; Jillian Royse; Lynda M Blayney; Karl Swann; F Anthony Lai
Journal:  Development       Date:  2002-08       Impact factor: 6.868

View more
  26 in total

1.  Regulation of OX1 orexin/hypocretin receptor-coupling to phospholipase C by Ca2+ influx.

Authors:  L Johansson; M E Ekholm; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2006-11-20       Impact factor: 8.739

2.  1p36.32 rearrangements and the role of PI-PLC η2 in nervous tumours.

Authors:  Vincenza Rita Lo Vasco
Journal:  J Neurooncol       Date:  2010-09-29       Impact factor: 4.130

3.  The potential role of postsynaptic phospholipase C activity in synaptic facilitation and behavioral sensitization in Aplysia.

Authors:  Daniel Fulton; Michael C Condro; Kaycey Pearce; David L Glanzman
Journal:  J Neurophysiol       Date:  2008-05-14       Impact factor: 2.714

4.  Structural basis for calcium and phosphatidylserine regulation of phospholipase C δ1.

Authors:  Jon W Lomasney; Hwei-Fang Cheng; Minae Kobayashi; Klim King
Journal:  Biochemistry       Date:  2012-03-09       Impact factor: 3.162

5.  Lipid Signaling in Tumorigenesis.

Authors:  Renyan Liu; Ying Huang
Journal:  Mol Cell Pharmacol       Date:  2014-01-01

6.  Tumor progression locus 2 mediates signal-induced increases in cytoplasmic calcium and cell migration.

Authors:  Maria Hatziapostolou; Georgios Koukos; Christos Polytarchou; Filippos Kottakis; Oksana Serebrennikova; Athan Kuliopulos; Philip N Tsichlis
Journal:  Sci Signal       Date:  2011-08-23       Impact factor: 8.192

7.  PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.

Authors:  Dailing Mao; Holly Epple; Brian Uthgenannt; Deborah V Novack; Roberta Faccio
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

8.  Lypopolysaccharide downregulates the expression of selected phospholipase C genes in cultured endothelial cells.

Authors:  V R Lo Vasco; M Leopizzi; C Chiappetta; C Puggioni; C Della Rocca; P Polonia; R Businaro
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 9.  Phosphoinositide pathway and the signal transduction network in neural development.

Authors:  Vincenza Rita Lo Vasco
Journal:  Neurosci Bull       Date:  2012-11-14       Impact factor: 5.203

10.  Characterization of phospholipase C gamma enzymes with gain-of-function mutations.

Authors:  Katy L Everett; Tom D Bunney; Youngdae Yoon; Fernando Rodrigues-Lima; Richard Harris; Paul C Driscoll; Koichiro Abe; Helmut Fuchs; Martin Hrabé de Angelis; Philipp Yu; Wohnwa Cho; Matilda Katan
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.